Automated, continuous and non-invasive assessment of pulse pressure variations using CNAP system.

J Clin Monit Comput

Adaptation cardiovasculaire à l'ischémie, U1034, INSERM, 33600, Pessac, France.

Published: August 2017

AI Article Synopsis

  • Non-invasive infrared-plethysmography (PPV) can predict fluid responsiveness in ventilated patients but lacks continuous monitoring.
  • A new algorithm for continuous PPV measurement was tested on 35 vascular surgery patients, comparing it with traditional invasive methods.
  • The study found that PPV thresholds of 14% and 15% accurately identified patients who would benefit from fluid volume expansion, indicating both methods perform well for assessing fluid responsiveness in stable patients.

Article Abstract

Non-invasive respiratory variations in arterial pulse pressure using infrared-plethysmography (PPV) are able to predict fluid responsiveness in mechanically ventilated patients. However, they cannot be continuously monitored. The present study evaluated a new algorithm allowing continuous measurements of PPV (PPV) (CNSystem, Graz, Austria). Thirty-five patients undergoing vascular surgery were studied after induction of general anaesthesia. Stroke volume was measured using the Vigileo/FloTrac. Invasive pulse pressure variations were manually calculated using an arterial line (PPV) and PPV was continuously displayed. PPV and PPV were simultaneously recorded before and after volume expansion (500 ml hydroxyethylstarch). Subjects were defined as responders if stroke volume increased by ≥15 %. Twenty-one patients were responders. Before volume expansion, PPV and PPV exhibited a bias of 0.1 % and limits of agreement from -7.9 % to 7.9 %. After volume expansion, PPV and PPV exhibited a bias of -0.4 % and limits of agreement from -5.3 % to 4.5 %. A 14 % baseline PPV threshold discriminated responders with a sensitivity of 86 % (95 % CI 64-97 %) and a specificity of 100 % (95 % CI 77-100 %). Area under the receiver operating characteristic (ROC) curve for PPV was 0.93 (95 % CI 0.79-0.99). A 15 % baseline PPV threshold discriminated responders with a sensitivity of 76% (95 % CI 53-92 %) and a specificity of 93 % (95 % CI 66-99 %). Area under the ROC curves for PPV was 0.91 (95 % CI 0.76-0.98), which was not different from that for PPV. When compared with PPV, PPV performs satisfactorily in assessing fluid responsiveness in hemodynamically stable surgical patients.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10877-016-9899-4DOI Listing

Publication Analysis

Top Keywords

ppv ppv
24
ppv
18
pulse pressure
12
volume expansion
12
pressure variations
8
fluid responsiveness
8
stroke volume
8
expansion ppv
8
ppv exhibited
8
exhibited bias
8

Similar Publications

Detection methods for carbapenem-resistant Pseudomonas aeruginosa in surface water and wastewater.

Sci Total Environ

January 2025

National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Department of Biotechnology, Technical University Delft, Delft, the Netherlands. Electronic address:

Water systems can act as an important reservoir for Pseudomonas aeruginosa, which can pose public health risks during human contact. Carbapenem resistance is one of the most concerning resistances in P. aeruginosa making it a high-priority pathogen according to the World Health Organization (WHO), due to its ability to cause difficult-to-treat infections.

View Article and Find Full Text PDF

Background: Plasma biomarkers have recently emerged to detect symptomatic Alzheimer Disease (AD), but have yet to be validated in preclinical AD populations, where Aβ accumulates in the brain but older adults are cognitively unimpaired (CU). In addition to AD pathologic plasma biomarkers (amyloid and tau), inflammatory markers can accurately detect symptomatic AD. We used pathologic and inflammatory plasma biomarkers to predict amyloid PET status in CU older adults.

View Article and Find Full Text PDF

Background: Recent results from clinical trials in Alzheimer's disease (AD) emphasize the importance of treating early-stage disease. However, recruitment of preclinical AD participants is difficult due to the lack of symptoms, and the costs and/or invasiveness of established CSF and PET tests. We aimed to investigate whether plasma p-tau217 could be used to pre-screen cognitively unimpaired (CU) potential participants for amyloid-β (Aβ) pathology to improve the efficiency of clinical trial recruitment.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Eli Lilly and Company, Indianapolis, IN, USA.

Background: Presence of amyloid pathology is used to identify patients who would benefit from novel amyloid-targeting therapies for Alzheimer's disease (AD). Whilst PET tracers are considered the gold standard for establishing the presence of amyloid pathology, they are costly and not widely accessible. Blood-based biomarkers, if interchangeable with PET, could help negate such an inequitable barrier to treatment.

View Article and Find Full Text PDF

Background: Early detection of dementia and cognitive impairment is recommended for persons 65 years and older during wellness primary care visits. The importance of early detection has increased with the availability of new treatments for early Alzheimer's disease (AD). However, there is no clear approach for early detection in primary care.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!